Point‐of‐Care High‐Sensitivity Troponin Use in an ESC ‐Type Pathway for Assessment of Possible Acute Myocardial Infarction in the Emergency Department
- 12 October 2025
- journal article
- research article
- Published by Wiley in Emergency Medicine Australasia
- Vol. 37 (5) , e70147
Abstract
This prospective observational study aimed to assess the diagnostic utility of point‐of‐care (POC) high‐sensitivity troponin (hs‐cTn) within an ED chest pain pathway. Patients had paired laboratory hs‐cTnT and POC hs‐cTnI on arrival. Clinical care utilised the hs‐cTnT result. Allocation to risk classes was compared between hs‐cTnT and POC hs‐cTnI. AMI was adjudicated blinded to the POC result. Of 184 patients, 14 (7.6%) had AMI. Twenty‐one (11.4%) had AMI ruled out by hs‐cTnT and 59 (32.1%) by POC, both with 100% sensitivity. The POC test returned invalid results in 17 patients (8.5%). A POC hs‐cTnI assay within a clinical pathway may effectively risk stratify for AMI.Keywords
Funding Information
- Canterbury Medical Research Foundation
- Siemens Healthineers
- Health Research Council of New Zealand (19/234)
This publication has 4 references indexed in Scilit:
- Improving Care with the First measurement of high-sensitivity troponin T (ICare-FirsT) to enable early rule out and reduce length of stay: a diagnostic and observational studyEmergency Medicine Journal, 2025
- Emergency department use of a high-sensitivity point-of-care troponin assay reduces length of stay: an implementation study preliminary reportEuropean Heart Journal: Acute Cardiovascular Care, 2024
- Protocol for Improving Care by FAster risk-STratification through use of high sensitivity point-of-care troponin in patients presenting with possible acute coronary syndrome in the EmeRgency department (ICare-FASTER): a stepped-wedge cluster randomised quality improvement initiativeBMJ Open, 2024
- Determination of a whole-blood single-test low-risk threshold for a point-of-care high-sensitivity troponin assayEmergency Medicine Journal, 2024